Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
Clinical trial NCT03300492 · RECRUITING
Trial details
- NCT number
- NCT03300492
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2026-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.